Labcyte Expands Presence in Chinese Market
Labcyte announced the selection of Tekon Biotech as its exclusive distributor in China, including Hong Kong and Taiwan.
“Tekon, one of the leading distributors in China, will be a great partner for us,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we expand in Asia, Tekon will help us broaden our existing user base in the pharmaceutical industry and the contract research organizations (CROs) that service them. Tekon will provide them with technology from Labcyte for industry-leading compound management, high-throughput and secondary screening. Our established customers in China will find that Tekon will give them an opportunity for more immediate support and interaction. Tekon will also introduce us to new users in the growing genomics market. We feel that with the Labcyte platforms, Tekon can meet the genomics customers’ needs for miniaturization, precision and accuracy while remaining contamination-free.”
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Giant nanomachine aids the immune system - A small but important step towards a successful immune reaction is performed by an impressive nanomachine - Researchers use simulations to understand how it works.
MIT nanotubes sniff out cancer agents in living cells - Chemical engineers use carbon nanotubes to monitor chemotherapy, detect toxins at the single-molecule level
Fishing for DNA to measure biodiversity - Identifying the fish species present in a river based on traces of their DNA: this method has been successfully tested at about 90 sites in Switzerland
BioTek Receives European Patent for Microplate Washer Technology
New high-throughput screening study may open up for future Parkinson's disease therapy
DNA mutations shed in blood predicts response to immunotherapy in patients with cancer
